Synthesis and Biological Evaluation of 1,4-Naphthoquinone-1,2,3-triazole Hybrids as Potential Antivenom Agents against Bothrops spp. Snake Venoms

Abstract Snakebite envenomation is a neglected tropical disease associated with substantial morbidity and mortality worldwide, highlighting the need for complementary approaches to conventional antivenom therapy. Herein, 12 1,4-naphthoquinone-1,2,3-triazole hybrids (6a–l) were investigated for their ability to inhibit toxic activities induced by the venoms of Bothrops jararaca and B. jararacussu. The compounds were obtained through an ultrasound-assisted copper-catalyzed azide–alkyne cycloaddition (CuAAC) between 2-(azidomethyl)-3-methylnaphthalene-1,4-dione (4) and terminal alkynes (5), affording the derivatives in 54–92% yields. Their effects on venom proteolytic, coagulant, and phospholipase A2 (PLA2) activities were evaluated after incubation with the venoms for 30 min at 37 °C. In addition, in silico ADME and toxicity analyses were performed to assess their physicochemical and pharmacokinetic properties. All compounds complied with Lipinski’s rule of five, although low predicted aqueous solubility was observed for some derivatives and a toxicity alert was identified for 6k. In vitro assays showed that most compounds inhibited venom proteolytic activity by 30–90%, with distinct responses depending on the venom species. Notably, 6i showed no inhibition against B. jararaca venom but reduced proteolytic activity of B. jararacussu by approximately 60%. Compounds 6c, 6g, and 6i also displayed selective inhibition of venom-induced fibrinogen coagulation. Regarding PLA2 activity, 6a completely inhibited the activity of B. jararaca venom, while 6b and 6h produced approximately 92% inhibition; against B. jararacussu, measurable inhibition was observed for 6a, 6e, and 6f. Overall, the results reveal compounds- and venom species-dependent inhibitory profiles and provide biological evidence supporting further investigation of 1,4-naphthoquinone-1,2,3-triazole hybrids as potential scaffolds for complementary approaches to snakebite envenomation.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-16
DOI
https://doi.org/10.1021/acsomega.6c09242
Primary Topic
Venomous Animal Envenomation and Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Synthesis and Biological Evaluation of 1,4-Naphthoquinone-1,2,3-triazole Hybrids as Potential Antivenom Agents against Bothrops spp. Snake Venoms

Fernando de Carvalho da Silva, Luana da Silva Magalhães Forezi, Mariana de Oliveira Leal Desmarais, André Lopes Fuly et al.
3 links
ACS Omega
Venomous Animal Envenomation and Studies
article

Synthesis and Biological Evaluation of 1,4-Naphthoquinone-1,2,3-triazole Hybrids as Potential Antivenom Agents against Bothrops spp. Snake Venoms

Fernando de Carvalho da Silva, Luana da Silva Magalhães Forezi, Mariana de Oliveira Leal Desmarais, André Lopes Fuly, Brenda Bairral de Oliveira, Vitor Francisco Ferreira, Eladio F. Sanchez, Andresa N. de Lima Silva, Isadora M. G. Andrade, Ruan C. B. Ribeiro
article en

Abstract

Abstract Snakebite envenomation is a neglected tropical disease associated with substantial morbidity and mortality worldwide, highlighting the need for complementary approaches to conventional antivenom therapy. Herein, 12 1,4-naphthoquinone-1,2,3-triazole hybrids (6a–l) were investigated for their ability to inhibit toxic activities induced by the venoms of Bothrops jararaca and B. jararacussu. The compounds were obtained through an ultrasound-assisted copper-catalyzed azide–alkyne cycloaddition (CuAAC) between 2-(azidomethyl)-3-methylnaphthalene-1,4-dione (4) and terminal alkynes (5), affording the derivatives in 54–92% yields. Their effects on venom proteolytic, coagulant, and phospholipase A2 (PLA2) activities were evaluated after incubation with the venoms for 30 min at 37 °C. In addition, in silico ADME and toxicity analyses were performed to assess their physicochemical and pharmacokinetic properties. All compounds complied with Lipinski’s rule of five, although low predicted aqueous solubility was observed for some derivatives and a toxicity alert was identified for 6k. In vitro assays showed that most compounds inhibited venom proteolytic activity by 30–90%, with distinct responses depending on the venom species. Notably, 6i showed no inhibition against B. jararaca venom but reduced proteolytic activity of B. jararacussu by approximately 60%. Compounds 6c, 6g, and 6i also displayed selective inhibition of venom-induced fibrinogen coagulation. Regarding PLA2 activity, 6a completely inhibited the activity of B. jararaca venom, while 6b and 6h produced approximately 92% inhibition; against B. jararacussu, measurable inhibition was observed for 6a, 6e, and 6f. Overall, the results reveal compounds- and venom species-dependent inhibitory profiles and provide biological evidence supporting further investigation of 1,4-naphthoquinone-1,2,3-triazole hybrids as potential scaffolds for complementary approaches to snakebite envenomation.

ACS Omega
Universidade Federal Fluminense (BR), Ezequiel Dias Foundation (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Good health and well-being
Venomous Animal Envenomation and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon